The Global Pandemic of Falsified Medicines: Laboratory and Field Innovations and Policy Implications
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Globally, it is estimated that about 10–30% of pharmaceuticals are of poor quality. Poor-quality drugs lead to long-term drug resistance, create morbidity, and strain the financial structure of the health system. The current technologies for substandard drug detection either are too expensive for low-resource regions or only provide qualitative results. To address the current limitations with point-of-care technologies, we have developed an affordable and robust assay to quantify the amount of active pharmaceutical ingredients (APIs) to test product quality. Our novel assay consists of two parts: detection reagent (probe) and a microfluidic testing platform. As antimalarials are of high importance in the global fight against malaria and are often substandard, they are chosen as the model to validate our assay. As a proof-of-concept, we have tested the assay with artesunate pure and substandard samples (Arsuamoon tablets) from Africa and compared with the conventional 96-well plate with spectrophotometer to demonstrate the quantitative efficacy and performance of our system.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

Loading full text...

Full text loading...



  1. Newton PN, White NJ, Rozendaal JA, Green MD, , 2002. Murder by fake drugs. BMJ 324: 800801.[Crossref]
  2. Gostin LO, Buckley GJ, , 2013. Countering the Problem of Falsified and Substandard Drugs. Washington, DC: National Academies Press.[Crossref]
  3. Nikolin B, Imamovic B, Medanhodzic-Vuk S, Sober M, , 2004. High perfomance liquid chromatography in pharmaceutical analyses. Bosn J Basic Med Sci 4: 59.
  4. Primera Scientific LLC, 2014. Agilent: HPLC System. Available at: http://www.primerasci.com/product/hplc_system. Accessed April 23, 2014.
  5. Gardiner D, , 1989. Practical Raman Spectroscopy. Berlin, Germany: Springer-Verlag.[Crossref]
  6. Markert H, Ring J, Campbell N, , 2011. A comparison of four commercially available portable Raman spectrometers. National Forensic Science Technology Center 727: 18.
  7. Wang Y, Li Z, Zhang Z, An D, , 2004. Applications of Raman spectroscopy in pharmaceutical analysis. Acta Pharm Sin 39: 764768.
  8. Crecelius A, Clench MR, Richards DS, , 2003. TLC–MALDI in pharmaceutical analysis. LCGC Europe 19: 26.
  9. World Health Organization, 2011. Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa. Available at: http://www.who.int/medicines/publications/WHO_QAMSA_report.pdf. Accessed October 9, 2014.
  10. Global Health Pharma Fund, 2014. The GPHF-Minilab—Protection Against Counterfeit Medicine. Available at: http://www.gphf.org/web/en/minilab. Accessed April 23, 2014.
  11. Global Health Pharma Fund, 2014. GPHF-Minilab—Fact Sheet. Available at: http://www.gphf.org/web/en/minilab/factsheet.htm. Accessed April 23, 2014.
  12. Cui L, Yan G, Sattabongkot J, Chen B, Cao Y, Fan Q, Parker D, , 2012. Challenges and prospects for malaria elimination in the Greater Mekong Subregion. Acta Trop 121: 240245.[Crossref]
  13. Olliaro P, , 2005. Drug resistance hampers our capacity to roll back malaria. Clin Infect Dis 41 (Suppl 4): S247S257.[Crossref]
  14. Dondorp A, Newton P, Mayxay M, Van Damme W, Smithuis F, Yeung S, Petit A, , 2004. Fake antimalarials in southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials. Trop Med Int Health 9: 12411246.[Crossref]
  15. Nayyar GML, Breman JG, Newton PN, Herrington J, , 2012. Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis 12: 488496.[Crossref]
  16. World Health Organization, 2013. Q and A on Artemisinin Resistance. Available at: http://www.who.int/malaria/media/artemisinin_resistance_qa/en/. Accessed April 25, 2014.
  17. Cockburn R, Newton P, Agyarko K, Akunyili D, White N, , 2005. The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med 2: 302307.[Crossref]
  18. Nayyar GM, Breman JG, Newton PN, Herrington J, , 2012. Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet 12: 488496.[Crossref]
  19. Bate R, Coticetli P, Tren R, Attaran A, , 2008. Antimalarial drug quality in the most severely malarious parts of Africa—a six country study. PLoS ONE 3: e2132.[Crossref]
  20. Nyadong L, Late S, Green MD, Banga A, Fernandez FM, , 2007. Direct quantitation of active ingradients in solid artesunate antimalarial by noncovalent complex forming reactive desorption electrospray ionization mass spexctrometry. J Am Soc Mass Spectrom 19: 380388.[Crossref]
  21. Green MD, Mount DL, Wirtz RA, White NJ, , 2000. A colorimetric field method to assess the authenticity of drugs sold as the antimalarial artesunate. J Pharm Biomed Anal 24: 6570.[Crossref]
  22. Koesdjojo MT, Wu Y, Boonloed A, Dunfield EM, Remcho VT, , 2014. Low cost, high-speed identification of counterfeit antimalarial drugs on paper. Talanta 130: 122127.[Crossref]
  23. Krishna S, Uhlemann AC, Haynes RK, , 2004. Artemisinins: mechanisms of action and potential for resistance. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy. Drug Resistance Updates 7: 233244.[Crossref]
  24. Bluestarforensic, 2004. The Chemistry of BluestarForensic. Available at: http://www.bluestar-forensic.com/gb/bluestar-chemistry.php. Accessed October 8, 2014.
  25. University of Bristol, 2002. Mechanism of Reaction of Luminol. Available at: http://www.chm.bris.ac.uk/webprojects2002/fleming/mechanism.htm. Accessed May 2, 2014.
  26. Bowles D, Olson A, Hodges N, Heglund D, Vargas R, Williams S, , 2012. Chemiluminescent identification and quantification of artemisinin and relevant sesquiterpene lactone derivatives. Appl Spectrosc 66: 175179.[Crossref]
  27. ICH Expert Working Group, 2005. Validation of analytical procedures: text and methodology Q2(R1). International conference on harmonization of technical requirements for registration of pharmaceuticals for human use. Available at: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf. Accessed May 2, 2014.
  28. World Health Organization, 2011. Amodiaquine 150 mg/Artesunate 50 mg tbl—Summary of Product Characteristics. Available at: http://apps.who.int/prequal/whopar/whoparproducts/MA046part4v1.pdf. Accessed February 20, 2014.
  29. Stroock AD, Dertinger SKW, Ajdari A, Mezic I, Stone HA, Whitesides GM, , 2002. Chaotic mixer for microchannels. Science 295: 647651.[Crossref]
  30. Micro-chem, 2000. SU-8 2000 Permanent Epoxy Negative Photoresist Processing Guidelines for: SU-8 2100 and 2150. Available at: http://www.microchem.com/pdf/SU-82000DataSheet2100and2150Ver5.pdf. Accessed April 23, 2014.
  31. Cheeseman R, , 1999. Direct sensitivity comparison of fluorescein and luminol. JFI 49: 261268.
  32. United States Pharmacopeia, 2012. Artesunate for Injection. Available at: https://mc.usp.org/monographs/artesunate-for-injection-1-0?destination=node/861. Accessed October 9, 2014.
  33. VWR, 2014. SpectraMax® M2/M2e Multimode Microplate Readers, with SoftMax® Pro Software, Molecular Devices. Available at: https://us.vwr.com/store/catalog/product.jsp?catalog_number=89429-532. Accessed May 5, 2014.

Data & Media loading...

Supplementary Data

Supplementary PDF

  • Received : 25 Jun 2014
  • Accepted : 14 Mar 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error